Related references
Note: Only part of the references are listed.Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry
Anna Marie Mulligan et al.
CLINICAL CANCER RESEARCH (2013)
Recognizing and reversing the immunosuppressive tumor microenvironment of head and neck cancer
Charles C. L. Tong et al.
IMMUNOLOGIC RESEARCH (2012)
The role of CXCR2 chemokine receptors in the oral squamous cell carcinoma
Juliana Romanini et al.
INVESTIGATIONAL NEW DRUGS (2012)
The importance of stromal inflammation in squamous cell carcinoma of the tongue
Lotta Lundqvist et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2012)
The clinical implications of antitumor immunity in head and neck cancer
Clint T. Allen et al.
LARYNGOSCOPE (2012)
Transcriptional Profiling of Formalin Fixed Paraffin Embedded Tissue: Pitfalls and Recommendations for Identifying Biologically Relevant Changes
Matilda Rentoft et al.
PLOS ONE (2012)
New advances in molecular approaches to head and neck squamous cell carcinoma
Nivedita Sahu et al.
ANTI-CANCER DRUGS (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Differences in p63 expression in SCCHN tumours of different sub-sites within the oral cavity
Linda Boldrup et al.
ORAL ONCOLOGY (2011)
Analysis of chemokine and chemokine receptor expression in squamous cell carcinoma of the head and neck (SCCHN) cell lines
Hendrik A. Wolff et al.
RADIATION AND ENVIRONMENTAL BIOPHYSICS (2011)
CXCR3/Ligands Are Significantly Involved in the Tumorigenesis of Basal Cell Carcinomas
Blanche Ka Ki Lo et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Pathological complete response after preoperative systemic therapy and outcome: relevance of clinical and biologic baseline features
Emilia Montagna et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Dipyrimidine Amines: A Novel Class of Chemokine Receptor. Type 4 Antagonists with High Specificity
Aizhi Zhu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Therapeutic antibodies directed at G protein-coupled receptors
Catherine J. Hutchings et al.
MABS (2010)
Tubulin alpha-6 chain is a stably expressed reference gene in archival samples of normal oral tissue and oral squamous cell carcinoma
Matilda Rentoft et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2010)
Effective Immunotherapy against Murine Gliomas Using Type 1 Polarizing Dendritic Cells-Significant Roles of CXCL10
Mitsugu Fujita et al.
CANCER RESEARCH (2009)
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer
Yoichi Matsuo et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Epigenetic Silencing of CRABP2 and MX1 in Head and Neck Tumors
Marilia F. Calmon et al.
NEOPLASIA (2009)
The role of CXC chemokines and their receptors in cancer
Jo Vandercappellen et al.
CANCER LETTERS (2008)
Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells
Satoko Matsumura et al.
JOURNAL OF IMMUNOLOGY (2008)
Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: Implications for therapy
Jun Wang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10
Xiao-Ling Lu et al.
VACCINE (2008)
Metastasis of squamous cell carcinoma of the oral tongue
Daisuke Sano et al.
CANCER AND METASTASIS REVIEWS (2007)
Clinical and biological factors affecting response to radiotherapy in patients with head and neck cancer: a review
P. Silva et al.
CLINICAL OTOLARYNGOLOGY (2007)
Oral tongue cancer in young patients: A matched analysis
Werner Garavello et al.
ORAL ONCOLOGY (2007)
Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes
K. Kawada et al.
ONCOGENE (2007)
Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis
Sofie Struyf et al.
CANCER RESEARCH (2007)
Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment
Benjamin J. Moeller et al.
CANCER AND METASTASIS REVIEWS (2007)
CXCL10 promotes invasion-related properties in human colorectal carcinoma cells
Adi Zipin-Roitman et al.
CANCER RESEARCH (2007)
Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention?
W. Andrew Yeudall et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2007)
Identification of a gene signature for rapid screening of oral spuamous cell carcinoma
Amy F. Ziober et al.
CLINICAL CANCER RESEARCH (2006)
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis
Moritz N. Wente et al.
CANCER LETTERS (2006)
Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer
Tonya C. Walser et al.
CANCER RESEARCH (2006)
Radical radiotherapy in head and neck squamous cell carcinoma: An analysis of prognostic and therapeutic factors
K. A. Dinshaw et al.
CLINICAL ONCOLOGY (2006)
Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy
A Muller et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
CXCR3-binding chemokines in multiple myeloma
A Pellegrino et al.
CANCER LETTERS (2004)
The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines
L Goldberg-Bittman et al.
IMMUNOLOGY LETTERS (2004)
Matched analysis of survival in patients with squamous cell carcinoma of the head and neck diagnosed before and after 40 years of age
KB Pytynia et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2004)
Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes
K Kawada et al.
CANCER RESEARCH (2004)
Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma
S Shintani et al.
CANCER SCIENCE (2003)
Incidence and survival of squamous cell carcinoma of the tongue in Scandinavia, with special reference to young adults
K Annertz et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer
SP Schantz et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2002)
Pathologic complete remission after preoperative intracavitary radiotherapy of cervical cancer stage Ib and IIa is a strong prognostic factor for long-term survival: analysis of the Radiumhemmet data 1989-1991
C Beskow et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2002)
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity
CL Addison et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
